- HealthTech
- Tuesday, 09 Jun 2020
WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States
The new clinical manufacturing facility will install total 6000 L bioreactors, Process Development (PD), Quality Control (QC) labs, along with supporting functions. The 66,000-square-foot facility is expected to become operational in late 2020 and will bring in up to 100 jobs to the region.
This news follows WuXi Biologics' recent purchase of land to build a new 107,000-square-foot clinical and commercial manufacturing facility in Worcester, Massachusetts, and the lease of a 33,000-square-foot site to establish a process development lab in King of Prussia, Pennsylvania.
"We are excited to announce our third site in the United States and proud to become a member of the New Jersey community. Cranbury is a growing hub for the biotech and biopharma industries, and we look forward to working with and serving our partners in the area to benefit patients worldwide," said Dr. Chris Chen, CEO of WuXi Biologics.
Related Industry Updates
CT Scanner Market is expected to reach US$ 9,596.26 million by 2030
Dec 21, 2023
Healthcare Tele-Consultation Services Market Demand, Research Analysis, Thoughtful Insights, Facts, Historical Data & Future Forecast 2027
Dec 14, 2020
South and Central America Medical Writing Market In-Depth Study during 2019-2027 with CAGR of 6.6%| Business Market Insights
Apr 09, 2021
US Digital Pharmacy Market is expected to reach US$ 2,40,216.87 million by 2030
Sep 27, 2023
Astonishing Growth of Europe Cochlear Implants Market Trends, Demand, Share, Analysis To 2027 by Leading Players Sonova, Nurotron Biotechnology Co. Ltd., Medtronic, Demant A/S, Starkey, WIDEX A/S, Amplifon, GN Hearing A/S
Jan 05, 2021
Endoscopy Devices Market 2020 Global Industry Analysis, Emerging Trends, Product Value, Growth, Demand, Gross Margin, Revenue And Forecast To 2025
Apr 28, 2021
4D Printing In Healthcare Market by Regional Outlook, Latest Trend, Share Analysis, Growth, Application and Forecast to 2027
Apr 07, 2021
Follow us on
